Pfizer (NYSE:PFE) and its partner BioNTech (NASDAQ:BNTX) are hoping to have an opportunity to win authorization for their COVID-19 vaccine in India. The heavily populated country currently faces a COVID-19 crisis. In this Motley Fool Live video recorded on May 5, Motley Fool contributors Keith Speights and Brian Orelli discuss just how big Pfizer's opportunity in India could be.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,